Search research articles
Contact Us
Filters
Showing results (161-170 of 196) with videos related to
Page
of 20
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 23, 2025
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial
Edward Chesney, Dominic Oliver, Ananya Sarma, et al.
Psychopharmacology
|
April 21, 2022
The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study
Michael A P Bloomfield, Yumeya Yamamori, Chandni Hindocha, et al.
Psychological Medicine
|
August 8, 2025
The impact of childhood trauma and cannabis use on paranoia: a structural equation model approach
Giulia Trotta, Edoardo Spinazzola, Hannah Degen, et al.
Addiction (Abingdon, England)
|
March 19, 2026
Associations of cannabis use, tobacco use and co-use with brain volume: A systematic review and meta-analysis
Katherine Sawyer, Tom P Freeman, Martine Skumlien, et al.
Psychopharmacology
|
May 7, 2026
A mindfulness-based intervention to reduce altered brain reward function in cannabis use disorder: a double-blind, active and passive, randomised controlled fMRI trial
Emillie Beyer, Martine Skumlien, Govinda Poudel, et al.
Neuroscience and Biobehavioral Reviews
|
June 4, 2026
The subjective effects of △9-tetrahydrocannabinol: A systematic review and dose-response meta-regression
Isabella Goodwin, Dominic Oliver, Edward Chesney, et al.
The Lancet. Psychiatry
|
August 1, 2020
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Tom P Freeman, Chandni Hindocha, Gianluca Baio, et al.
Comprehensive Psychiatry
|
January 15, 2026
Attentional bias in people with moderate-to-severe cannabis use disorder
Marianna Quinones-Valera, Gary Chan, Madeleine I Fraser, et al.
Addiction (Abingdon, England)
|
June 27, 2025
Synthetic cannabinoids in e-cigarettes seized from English schools
Gyles E Cozier, Matthew Gardner, Sam Craft, et al.
The FEBS Journal
|
January 28, 2023
Synthetic cannabinoid receptor agonists are monoamine oxidase-A selective inhibitors
Sarah A Hindson, Rachael C Andrews, Michael J Danson, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 196) with videos related to
Sort By:
Page
of 20
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 23, 2025
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial
Edward Chesney, Dominic Oliver, Ananya Sarma, et al.
Psychopharmacology
|
April 21, 2022
The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study
Michael A P Bloomfield, Yumeya Yamamori, Chandni Hindocha, et al.
Psychological Medicine
|
August 8, 2025
The impact of childhood trauma and cannabis use on paranoia: a structural equation model approach
Giulia Trotta, Edoardo Spinazzola, Hannah Degen, et al.
Addiction (Abingdon, England)
|
March 19, 2026
Associations of cannabis use, tobacco use and co-use with brain volume: A systematic review and meta-analysis
Katherine Sawyer, Tom P Freeman, Martine Skumlien, et al.
Psychopharmacology
|
May 7, 2026
A mindfulness-based intervention to reduce altered brain reward function in cannabis use disorder: a double-blind, active and passive, randomised controlled fMRI trial
Emillie Beyer, Martine Skumlien, Govinda Poudel, et al.
Neuroscience and Biobehavioral Reviews
|
June 4, 2026
The subjective effects of △9-tetrahydrocannabinol: A systematic review and dose-response meta-regression
Isabella Goodwin, Dominic Oliver, Edward Chesney, et al.
The Lancet. Psychiatry
|
August 1, 2020
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Tom P Freeman, Chandni Hindocha, Gianluca Baio, et al.
Comprehensive Psychiatry
|
January 15, 2026
Attentional bias in people with moderate-to-severe cannabis use disorder
Marianna Quinones-Valera, Gary Chan, Madeleine I Fraser, et al.
Addiction (Abingdon, England)
|
June 27, 2025
Synthetic cannabinoids in e-cigarettes seized from English schools
Gyles E Cozier, Matthew Gardner, Sam Craft, et al.
The FEBS Journal
|
January 28, 2023
Synthetic cannabinoid receptor agonists are monoamine oxidase-A selective inhibitors
Sarah A Hindson, Rachael C Andrews, Michael J Danson, et al.
Page
of 20